Karl Rickels
Overview
Explore the profile of Karl Rickels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balon R, Starcevic V, Silberman E, Cosci F, Dubovsky S, Fava G, et al.
Braz J Psychiatry
. 2020 Mar;
42(3):243-244.
PMID: 32159714
No abstract available.
2.
Balon R, Silberman E, Starcevic V, Cosci F, Freire R, Nardi A, et al.
J Psychopharmacol
. 2019 Sep;
33(11):1467-1470.
PMID: 31556796
No abstract available.
3.
Rickels K, Gallop R, Cleary S
J Clin Psychopharmacol
. 2019 Apr;
39(3):258-260.
PMID: 30932946
Purpose: The time course of adverse events is an important factor for patient management. Clinicians are better able to prepare patients for specific adverse events, which leads to better treatment...
4.
Rickels K, Moeller H
World J Biol Psychiatry
. 2018 Sep;
20(7):514-518.
PMID: 30252578
Benzodiazepines (BZs) are still widely prescribed for the treatment of anxiety disorders despite many publications in the literature which favour antidepressants (ADs) instead. What is the evidence? Treatment guidelines favour...
5.
Nardi A, Cosci F, Balon R, Weintraub S, Freire R, Krystal J, et al.
J Clin Psychopharmacol
. 2018 Jun;
38(4):283-285.
PMID: 29912790
No abstract available.
6.
Rickels K, Athanasiou M, Reed C
Per Med
. 2018 May;
6(2):217-224.
PMID: 29788607
Vilazodone is a novel antidepressant with a dual mechanism of action that combines selective serotonin reuptake inhibition and partial 5-hydroxytryptamine receptor agonism. Vilazodone is undergoing clinical development for the treatment...
7.
Balon R, Chouinard G, Cosci F, Dubovsky S, Fava G, Freire R, et al.
Psychother Psychosom
. 2018 May;
87(4):193-194.
PMID: 29788029
No abstract available.
8.
Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava G
Psychother Psychosom
. 2018 Feb;
87(2):65-74.
PMID: 29466801
Background: The aim of this paper was to perform a systematic review and, when feasible, a meta-analysis of randomized controlled trials (RCT) which used benzodiazepines (BZD) as a monotherapy versus...
9.
Rickels M, Perez E, Peleckis A, Alshehabi E, Nguyen H, Stefanovski D, et al.
Am J Physiol Endocrinol Metab
. 2018 Jan;
315(2):E250-E257.
PMID: 29351487
Atypical antipsychotic drugs have been associated with the development of obesity and diabetes. In particular, olanzapine can induce peripheral insulin resistance and compensatory hyperinsulinemia independent of weight gain or psychiatric...
10.
Fava G, Guidi J, Rafanelli C, Rickels K
Psychother Psychosom
. 2017 Nov;
86(6):332-340.
PMID: 29131050
Placebo effects are often attributed to clinical interactions and contextual factors that affect expectations of the patient about the treatment and result in symptom changes. The prevailing conceptualization consists of...